Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print October 11, 2001, 10.1148/radiol.2213010220
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2213010220v1
221/3/822    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bjerner, T.
Right arrow Articles by Ahlström, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bjerner, T.
Right arrow Articles by Ahlström, H.
(Radiology. 2001;221:822-826.)
© RSNA, 2001


Technical Developments

First-Pass Myocardial Perfusion MR Imaging with Outer-Volume Suppression and the Intravascular Contrast Agent NC100150 Injection: Preliminary Results in Eight Patients1

Tomas Bjerner, MD, Lars Johansson, Anders Ericsson, PhD, Gerhard Wikström, MD, PhD, Anders Hemmingsson, MD, PhD and Håkan Ahlström, MD, PhD

1 From the Departments of Radiology (T.B., L.J., A.E., A.H., H.A.) and Cardiology (G.W.), University Hospital, S-751 85 Uppsala, Sweden; and Nycomed Amersham Imaging, Oslo, Norway (L.J.). Received January 3, 2001; revision requested February 14; revision received April 24; accepted May 21. Supported in part by Nycomed Amersham Imaging and Swedish Medical Research Council project 6676. Address correspondence to T.B. (e-mail: Tomas.Bjerner@radiol.uu.se).

The authors evaluated the feasibility of combining single-shot T2-weighted turbo spin-echo magnetic resonance (MR) imaging and first-pass myocardial perfusion MR imaging with an intravascular ultrasmall superparamagnetic iron oxide (USPIO) contrast agent, NC100150 Injection (3 mg of iron per kilogram of body weight). Eight patients with coronary vessel disease underwent T2-weighted turbo spin-echo MR imaging (in-plane resolution, 1–2 mm) during the first pass of the USPIO contrast agent. The mean decrease in signal intensity in myocardium perfused by a nonstenotic coronary artery was 59% ± 13 (SD) (P < .012) This method is feasible for imaging of myocardial perfusion.

Index terms: Heart, perfusion, 511.12144 • Magnetic resonance (MR), contrast enhancement, 511.12143 • Myocardium, blood supply, 511.76, 511.771 • Myocardium, MR, 511.121412




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
A R Padhani
MRI for assessing antivascular cancer treatments
Br. J. Radiol., December 1, 2003; 76(suppl_1): S60 - S80.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2001 by the Radiological Society of North America.